Case number 2018-1885
Pfizer, Inc. v. Biogen, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 20, 2019 | 66 | ORDER filed. The motion [65] is granted to the extent that the appeal is dismissed. All other pending motions [48] [56] [57] are denied as moot. Each side shall bear its own costs. ISSUED AS A MANDATE: March 20, 2019. Service: 03/20/2019 by clerk. [594135] [LMS] [Entered: 03/20/2019 10:30 AM] (0) |
| Mar 15, 2019 | 65 | MOTION of Appellees Biogen, Inc., Genentech, Inc. and Appellant Pfizer, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 03/15/2019 by email. [593355] [18-1885] [Charles Klein] [Entered: 03/15/2019 04:40 PM] (0) |
| Jan 24, 2019 | 62 | 6 paper copies of the Reply Brief [49] received from Appellant Pfizer, Inc.. [580577] [CJF] [Entered: 01/24/2019 12:48 PM] (0) |
| Jan 24, 2019 | 63 | 6 paper copies of the Confidential Joint Appendix Brief (Vol. I - II) [53] received from Appellant Pfizer, Inc.. [580583] [CJF] [Entered: 01/24/2019 01:00 PM] (0) |
| Jan 24, 2019 | 64 | Notice from Appellees Biogen, Inc. and Genentech, Inc. regarding conflicts with oral argument. Service: 01/24/2019 by email. [580588] [18-1885] [Nicholas Groombridge] [Entered: 01/24/2019 01:07 PM] (0) |
| Jan 22, 2019 | 61 | Notice from Appellant Pfizer, Inc. regarding conflicts with oral argument. Service: 01/22/2019 by email. [579541] [18-1885] [Charles Klein] [Entered: 01/22/2019 09:23 AM] (0) |
| Jan 18, 2019 | 59 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 01/25/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [579206] [MJL] [Entered: 01/18/2019 08:34 AM] (0) |
| Jan 18, 2019 | 60 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [579208] [MJL] [Entered: 01/18/2019 08:35 AM] (0) |
| Jan 17, 2019 | 58 | ORDER filed. The motions [48] [56] [57] are deferred to the merits panel assigned to this case. A copy of the motions papers and this order shall be transmitted to the merits panel assigned to this appeal.; - FOR CALENDAR. (Per Curiam). Service: 01/17/2019 by clerk. [578898] [LMS] [Entered: 01/17/2019 11:12 AM] (0) |
| Dec 28, 2018 | 57 | MOTION of Appellant Pfizer, Inc. for leave to file a response/reply to [56] motion to strike document [Consent: not addressed]. Service: 12/28/2018 by email. [574955] [18-1885] [Charles Klein] [Entered: 12/28/2018 01:24 PM] (0) |
| Dec 21, 2018 | 56 | MOTION of Appellees Biogen, Inc. and Genentech, Inc. to strike Brief [49], confidential Brief [53], Brief [54] [Consent: opposed]. Service: 12/21/2018 by email. [574261] [18-1885] [Nicholas Groombridge] [Entered: 12/21/2018 04:31 PM] (60) |
| Dec 21, 2018 | 55 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Pfizer, Inc.. Service: 12/21/2018 by email. [574236] [18-1885] [Charles Klein] [Entered: 12/21/2018 04:01 PM] (3) |
| Dec 21, 2018 | 54 | MODIFIED ENTRY: APPENDIX FILED for Pfizer, Inc. Number of Pages: 1326. Service: 12/21/2018 by email. [574220]--[Edited 01/17/2019 by MJL - compliance review complete (pending motion [48])] [Charles Klein] [Entered: 12/21/2018 03:47 PM] (1326) |
| Dec 21, 2018 | 53 | MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Pfizer, Inc.. Number of Pages: 1335. Service: 12/21/2018 by email. [574198]--[Edited 01/17/2019 by MJL - compliance review complete (pending motion [48])] [Charles Klein] [Entered: 12/21/2018 03:30 PM] (0) |
| Dec 20, 2018 | 52 | REPLY of Appellant Pfizer, Inc. to response filed by Appellees, Doc. No [51]. Service: 12/20/2018 by email. [573801] [18-1885] [Charles Klein] [Entered: 12/20/2018 09:29 PM] (11) |
| Dec 19, 2018 | 51 | RESPONSE of Appellees Biogen, Inc. and Genentech, Inc. to the motion to correct/supplement [48] filed by Appellant Pfizer, Inc.. Service: 12/19/2018 by email. [573307] [18-1885] [Nicholas Groombridge] [Entered: 12/19/2018 06:44 PM] (23) |
| Dec 19, 2018 | 50 | Amended Certificate of Interest for the Appellees Biogen, Inc. and Genentech, Inc.. Service: 12/19/2018 by email. [573306] [18-1885] [Nicholas Groombridge] [Entered: 12/19/2018 06:41 PM] (3) |
| Dec 14, 2018 | 49 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Pfizer, Inc. Number of Pages: 31. Service: 12/14/2018 by email. [572018]--[Edited 01/17/2019 by MJL - compliance review complete] [Charles Klein] [Entered: 12/14/2018 06:30 PM] (39) |
| Dec 13, 2018 | 48 | MOTION of Appellant Pfizer, Inc. to correct or supplement [Consent: opposed]. Service: 12/13/2018 by email. [571712] [18-1885] [Charles Klein] [Entered: 12/13/2018 08:15 PM] (381) |
| Nov 20, 2018 | 47 | 6 paper copies of the Opening Response Brief [43] received from Appellees Biogen, Inc. and Genentech, Inc.. [566603] [CJF] [Entered: 11/20/2018 09:50 AM] (0) |
| Nov 19, 2018 | 46 | Entry of appearance for Zachary B. Cohen as of counsel for Appellant Pfizer, Inc.. Service: 11/19/2018 by email. [566334] [18-1885] [Charles Klein] [Entered: 11/19/2018 02:14 PM] (2) |
| Nov 19, 2018 | 45 | Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellant Pfizer, Inc.. Service: 11/19/2018 by email. [566331] [18-1885] [Charles Klein] [Entered: 11/19/2018 02:13 PM] (2) |
| Nov 19, 2018 | 44 | Entry of appearance for Jovial Wong as of counsel for Appellant Pfizer, Inc.. Service: 11/19/2018 by email. [566328] [18-1885] [Charles Klein] [Entered: 11/19/2018 02:11 PM] (2) |
| Nov 15, 2018 | 42 | **TEXT ONLY** ORDER granting motions to extend time to file the appellant's reply brief [40] and [41] filed by Pfizer, Inc. The brief is due 12/14/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [565422] [MJL] [Entered: 11/15/2018 03:26 PM] (0) |
| Nov 14, 2018 | 41 | MOTION of Appellant Pfizer, Inc. to extend the time to 12/14/2018 to file the Appellant's Reply Brief. [Consent: unopposed]. Service: 11/14/2018 by email. [564752] [18-1885]--[Edited 11/15/2018 by MJL to remove incorrect relief] [Charles Klein] [Entered: 11/14/2018 10:53 AM] (9) |
| Nov 13, 2018 | 40 | MOTION of Appellant Pfizer, Inc. to extend the time to 12/14/2018 to file the Appellant's Reply Brief. [Consent: not addressed]. Service: 11/13/2018 by email. [564663] [18-1885] [Charles Klein] [Entered: 11/13/2018 08:44 PM] (9) |
| Nov 6, 2018 | 43 | BRIEF FILED for Appellees Biogen, Inc. and Genentech, Inc. [39]. Number of Pages: 56. Service: 11/06/2018 by email. The paper copies of the brief should be received by the court on or before 11/26/2018. [565425] [MJL] [Entered: 11/15/2018 03:28 PM] (66) |
| Nov 6, 2018 | 39 | TENDERED from Appellees Biogen, Inc. and Genentech, Inc.. Title: RESPONSE BRIEF. Service: 11/06/2018 by email. [563125] [18-1885] [Nicholas Groombridge] [Entered: 11/06/2018 08:52 PM] (66) |
| Nov 6, 2018 | 38 | Official caption revised to reflect dismissal of consolidated appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [562969] [SJ] [Entered: 11/06/2018 02:08 PM] (0) |
| Nov 6, 2018 | 37 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [36] filed by Appellant Celltrion, Inc.; issuing mandate in 18-1924. Service as of this date by the Clerk of Court. [562964] [18-1885, 18-1924] [SJ] [Entered: 11/06/2018 02:04 PM] (2) |
| Nov 2, 2018 | 36 | MOTION of Appellant Celltrion, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 11/02/2018 by email. [562217] [18-1885] [William Jay] [Entered: 11/02/2018 11:42 AM] (7) |
| Sep 13, 2018 | 35 | ORDER granting motions [26] and [33] filed by Appellees Genentech, Inc. and Biogen, Inc. Nicholas Groombridge has been entered as principal counsel for the parties. The response brief is due 11/06/2018. Service as of this date by the Clerk of Court. [549450] [MJL] [Entered: 09/13/2018 11:13 AM] (2) |
| Sep 11, 2018 | 29 | Entry of appearance for J. Steven Baughman as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549013] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:25 PM] (2) |
| Sep 11, 2018 | 34 | Entry of appearance for David I. Gindler as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549019] [18-1885] [David Gindler] [Entered: 09/11/2018 06:54 PM] (2) |
| Sep 11, 2018 | 27 | Entry of appearance for Nicholas Groombridge as principal counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549011] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:22 PM] (2) |
| Sep 11, 2018 | 28 | Entry of appearance for Jennifer H. Wu as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549012] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:24 PM] (2) |
| Sep 11, 2018 | 33 | MOTION of Appellees Biogen, Inc. and Genentech, Inc. to extend the time to 11/06/2018 to file the Responsive Brief. [Consent: unopposed]. Service: 09/11/2018 by email. [549018] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:38 PM] (9) |
| Sep 11, 2018 | 30 | Entry of appearance for Megan F. Raymond as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549014] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:27 PM] (2) |
| Sep 11, 2018 | 31 | Entry of appearance for Stephen A. Maniscalco as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549015] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:28 PM] (2) |
| Sep 11, 2018 | 32 | Amended Certificate of Interest for the Appellees Biogen, Inc. and Genentech, Inc.. Service: 09/11/2018 by email. [549016] [18-1885] [Nicholas Groombridge] [Entered: 09/11/2018 06:34 PM] (3) |
| Sep 7, 2018 | 26 | MOTION of Appellees Biogen, Inc. and Genentech, Inc. substituting Nicholas Groombridge of Paul, Weiss, Rifkind, Wharton, & Garrison LLP as principal attorney for Appellees in this appeal [Consent: unopposed]. Service: 09/07/2018 by email. [548244] [18-1885] [David Gindler] [Entered: 09/07/2018 07:11 PM] (5) |
| Aug 17, 2018 | 25 | 6 paper copies of the Opening Brief [22] received from Appellants Celltrion, Inc. and Pfizer, Inc.. [543715] [CJF] [Entered: 08/17/2018 11:42 AM] (0) |
| Aug 16, 2018 | 24 | Amended Certificate of Interest for the Appellant Celltrion, Inc.. Service: 08/16/2018 by email. [543349] [18-1885] [William Jay] [Entered: 08/16/2018 11:03 AM] (3) |
| Aug 16, 2018 | 23 | REMINDER: All counsel of record are reminded of their responsibility per FCR 47.3(c)(1) and FCR 47.4(c) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. The court notes that the COIs included in Appellants' brief [21] contain different information from the first filed COIs ([6], [14]). Appellants should promptly file updated COIs. [543310] [MJL] [Entered: 08/16/2018 09:53 AM] (0) |
| Aug 13, 2018 | 22 | BRIEF FILED for Appellants Celltrion, Inc. and Pfizer, Inc. [21]. Number of Pages: 46. Service: 08/13/2018 by email. The paper copies of the brief should be received by the court on or before 08/23/2018. Appellees' brief is due 09/24/2018. [543297] [MJL] [Entered: 08/16/2018 09:30 AM] (111) |
| Aug 13, 2018 | 21 | TENDERED from Appellants Pfizer, Inc. and Celltrion, Inc.. Title: OPENING BRIEF. Service: 08/13/2018 by email. [542541] [18-1885] [William Jay] [Entered: 08/13/2018 05:31 PM] (111) |
| Aug 13, 2018 | 20 | Entry of appearance for Huiya Wu as of counsel for Appellant Celltrion, Inc.. Service: 08/13/2018 by email. [542396] [18-1885] [Huiya Wu] [Entered: 08/13/2018 12:41 PM] (2) |
| Jun 13, 2018 | 19 | Certified list from the United States Patent and Trademark Office. Service: 06/13/2018 by email. Appellant's brief due 08/13/2018. [528966] [MJL] [Entered: 06/13/2018 09:27 AM] (41) |
| May 21, 2018 | 18 | Corrected Entry of appearance for Elizabeth J. Holland as of counsel for Appellant Celltrion, Inc.. Service: 05/21/2018 by email. [523064] [18-1885] [Elizabeth Holland] [Entered: 05/21/2018 07:34 AM] (2) |
| May 18, 2018 | 17 | Entry of appearance for Elizabeth J. Holland as of counsel for Appellant Celltrion, Inc.. Service: 05/18/2018 by email. [523017] [18-1885] [William Jay] [Entered: 05/18/2018 04:57 PM] (2) |
| May 18, 2018 | 16 | Entry of appearance for Gerard J. Cedrone as of counsel for Appellant Celltrion, Inc.. Service: 05/18/2018 by email. [522838] [18-1885] [Gerard Cedrone] [Entered: 05/18/2018 12:20 PM] (2) |
| May 18, 2018 | 15 | Docketing Statement for the Appellant Celltrion, Inc.. Service: 05/18/2018 by email. [522818] [18-1885] [William Jay] [Entered: 05/18/2018 11:49 AM] (4) |
| May 18, 2018 | 14 | Certificate of Interest for the Appellant Celltrion, Inc.. Service: 05/18/2018 by email. [522815] [18-1885] [William Jay] [Entered: 05/18/2018 11:48 AM] (3) |
| May 18, 2018 | 13 | Entry of appearance for William M. Jay as principal counsel for Appellant Celltrion, Inc.. Service: 05/18/2018 by email. [522814] [18-1885] [William Jay] [Entered: 05/18/2018 11:46 AM] (2) |
| May 11, 2018 | 12 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [10], ERROR: Attorney Keith A. Orso is not a registered ECF filer with this court. CORRECTION: Pursuant to Rule ECF-2, attorneys who appear before the court must register for ECF. Mr. Orso should register for ECF as soon as possible. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [520967] [CFT] [Entered: 05/11/2018 10:13 AM] (0) |
| May 10, 2018 | 11 | Entry of appearance for Gary N. Frischling as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 05/10/2018 by email, US mail. [520813] [18-1885] [Gary Frischling] [Entered: 05/10/2018 04:20 PM] (2) |
| May 10, 2018 | 10 | Entry of appearance for Keith A. Orso as of counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 05/10/2018 by email, US mail. [520789] [18-1885] [David Gindler] [Entered: 05/10/2018 03:48 PM] (2) |
| May 10, 2018 | 9 | Certificate of Interest for the Appellees Biogen, Inc. and Genentech, Inc.. Service: 05/10/2018 by email, US mail. [520787] [18-1885] [David Gindler] [Entered: 05/10/2018 03:46 PM] (4) |
| May 10, 2018 | 8 | Entry of appearance for David I. Gindler as principal counsel for Appellees Biogen, Inc. and Genentech, Inc.. Service: 05/10/2018 by email, US mail. [520786] [18-1885] [David Gindler] [Entered: 05/10/2018 03:44 PM] (2) |
| May 10, 2018 | 7 | Docketing Statement for the Appellees Biogen, Inc. and Genentech, Inc.. Service: 05/10/2018 by email, US mail. [520784] [18-1885] [David Gindler] [Entered: 05/10/2018 03:43 PM] (4) |
| May 10, 2018 | 6 | Certificate of Interest for the Appellant Pfizer, Inc.. Service: 05/10/2018 by email. [520733] [18-1885] [Charles Klein] [Entered: 05/10/2018 02:43 PM] (3) |
| May 10, 2018 | 5 | Docketing Statement for the Appellant Pfizer, Inc.. Service: 05/10/2018 by email. [520730] [18-1885] [Charles Klein] [Entered: 05/10/2018 02:40 PM] (4) |
| May 10, 2018 | 4 | Entry of appearance for Charles B. Klein as principal counsel for Appellant Pfizer, Inc.. Service: 05/10/2018 by email. [520726] [18-1885] [Charles Klein] [Entered: 05/10/2018 02:37 PM] (2) |
| May 8, 2018 | 3 | ORDER consolidating appeal 18-1885 with 18-1924. Service as of this date by the Clerk of Court. [520021] [18-1885, 18-1924] [CFT] [Entered: 05/08/2018 12:39 PM] (2) |
| May 8, 2018 | 2 | Note to file: The following cases are associated: 18-1885 Lead with 18-1924 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [520017] [18-1885, 18-1924] [CFT] [Entered: 05/08/2018 12:34 PM] (0) |
| Apr 26, 2018 | 1 | Appeal docketed. Received: 04/25/2018. [516995] Entry of Appearance due 05/10/2018. Certificate of Interest due 05/10/2018. Docketing Statement due 05/10/2018. Certified List due 06/05/2018. [CFT] [Entered: 04/26/2018 09:21 AM] (6) |
